Health
SEROLOGICAL RESPONSES AFTER SARS‐COV‐2 VACCINATION FIRST DOSE IN PATIENTS WITH LYMPHOID MALIGNANCY: FIRST INTERIM ANALYSIS OF THE UK PROSECO STUDY – Wiley
Click on the article title to read more.
Introduction: COVID-19 is thought to be more frequent and severe in patients with cancer. Lymphoma patients may be especially vulnerable, due to the immunodeficiency and immune dysregulation caused by the lymphoma itself and the antitumor treatments. This…
Continue Reading
-
General23 hours agoDiamonds defeat Proteas 64-53 in first netball Test in Bendigo
-
General23 hours agoMitch Marsh inspires Australia to three-wicket win over New Zealand in third T20I
-
General22 hours agoNothing to see here *wink wink*
-
General21 hours agoNewcastle Jets defeat semi-professional Heidelberg United 3-1 to lift first Australia Cup